Daiken Medical Statistics

Total Valuation

Daiken Medical has a market cap or net worth of JPY 12.70 billion. The enterprise value is 11.75 billion.

Market Cap	12.70B
Enterprise Value	11.75B

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Daiken Medical has 28.73 million shares outstanding.

Current Share Class	28.73M
Shares Outstanding	28.73M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	48.78%
Owned by Institutions (%)	5.46%
Float	14.17M

Valuation Ratios

The trailing PE ratio is 11.58.

PE Ratio	11.58
Forward PE	n/a
PS Ratio	1.28
PB Ratio	1.69
P/TBV Ratio	1.69
P/FCF Ratio	13.31
P/OCF Ratio	11.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.74, with an EV/FCF ratio of 12.32.

EV / Earnings	10.71
EV / Sales	1.18
EV / EBITDA	6.74
EV / EBIT	7.77
EV / FCF	12.32

Financial Position

The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.27.

Current Ratio	2.47
Quick Ratio	1.93
Debt / Equity	0.27
Debt / EBITDA	1.18
Debt / FCF	2.15
Interest Coverage	168.00

Financial Efficiency

Return on equity (ROE) is 15.09% and return on invested capital (ROIC) is 10.09%.

Return on Equity (ROE)	15.09%
Return on Assets (ROA)	8.52%
Return on Invested Capital (ROIC)	10.09%
Return on Capital Employed (ROCE)	18.10%
Revenue Per Employee	56.86M
Profits Per Employee	6.27M
Employee Count	175
Asset Turnover	0.90
Inventory Turnover	4.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.05% in the last 52 weeks. The beta is 0.03, so Daiken Medical's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-19.05%
50-Day Moving Average	479.16
200-Day Moving Average	504.05
Relative Strength Index (RSI)	27.77
Average Volume (20 Days)	62,915

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daiken Medical had revenue of JPY 9.95 billion and earned 1.10 billion in profits. Earnings per share was 38.19.

Revenue	9.95B
Gross Profit	4.10B
Operating Income	1.51B
Pretax Income	1.51B
Net Income	1.10B
EBITDA	1.74B
EBIT	1.51B
Earnings Per Share (EPS)	38.19

Full Income Statement

Balance Sheet

The company has 3.00 billion in cash and 2.05 billion in debt, giving a net cash position of 944.00 million or 32.86 per share.

Cash & Cash Equivalents	3.00B
Total Debt	2.05B
Net Cash	944.00M
Net Cash Per Share	32.86
Equity (Book Value)	7.52B
Book Value Per Share	261.59
Working Capital	4.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.12 billion and capital expenditures -166.00 million, giving a free cash flow of 954.00 million.

Operating Cash Flow	1.12B
Capital Expenditures	-166.00M
Free Cash Flow	954.00M
FCF Per Share	33.21

Full Cash Flow Statement

Margins

Gross margin is 41.16%, with operating and profit margins of 15.19% and 11.02%.

Gross Margin	41.16%
Operating Margin	15.19%
Pretax Margin	15.14%
Profit Margin	11.02%
EBITDA Margin	17.53%
EBIT Margin	15.19%
FCF Margin	9.59%

Dividends & Yields

This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 4.05%.

Dividend Per Share	18.00
Dividend Yield	4.05%
Dividend Growth (YoY)	9.52%
Years of Dividend Growth	1
Payout Ratio	55.79%
Buyback Yield	n/a
Shareholder Yield	4.09%
Earnings Yield	8.64%
FCF Yield	7.51%

Dividend Details

Stock Splits

The last stock split was on November 13, 2014. It was a forward split with a ratio of 2.

Last Split Date	Nov 13, 2014
Split Type	Forward
Split Ratio	2

Scores

Daiken Medical has an Altman Z-Score of 5.29.

Altman Z-Score	5.29
Piotroski F-Score	n/a